Clinical Trials & Medical Discoveries The most recent news and results from scientific and medical research, covering all aspects of healthcare, including testing, diagnosis, and treatment. Stay up-to-date on the latest medical discoveries and breakthroughs with announcements of new products to be tested, upcoming clinical trials and studies, and newly published results. Also included are updates regarding funding decisions, company performance, and legal news.

Latest

20 Apr, 2017, 11:35 ET Lilly to Present Data for Galcanezumab for the Prevention of Migraine at the American Academy of Neurology (AAN) Annual Meeting

Eli Lilly and Company (NYSE: LLY) will highlight Phase 2 data evaluating galcanezumab for the prevention of migraine at the American Academy of...


20 Apr, 2017, 10:27 ET MT Pharma America to Present Data on Investigational Edaravone and Amyotrophic Lateral Sclerosis at the 2017 American Academy of Neurology Annual Meeting

MT Pharma America, Inc. (MTPA) today announced it will present four abstracts at the 69th Annual Meeting of the American Academy of Neurology (AAN)...


20 Apr, 2017, 10:20 ET Mead Johnson Nutrition : des leaders d'opinion dans le domaine de l'APLV discutent des dernières innovations dans la gestion alimentaire de la carrière allergique

L'Organisation mondiale de l'allergie estime qu'entre 1,9 % et 4,9 % des enfants souffrent d'une allergie aux protéines de lait de vache (APLV),...


20 Apr, 2017, 10:17 ET Mead Johnson Nutrition: Debate sobre las últimas innovaciones en tratamiento dietético de la 'marcha alérgica'

- Mead Johnson Nutrition: Los líderes más destacados en APLV debaten sobre las últimas innovaciones en tratamiento dietético de la marcha...


20 Apr, 2017, 10:15 ET Mead Johnson Nutrition: Vordenker in Sachen CMA diskutieren die neuesten Innovationen in der diätetischen Behandlung des Etagenwechsels bei Allergien

Die World Allergy Organization schätzt, dass 1,9 % bis 4,9 % aller Kinder mit einer Kuhmilchallergie (CMA) leben, was diese Erkrankung...


20 Apr, 2017, 10:13 ET Thought-leaders in CMA Discuss the Latest Innovations in the Dietary Management of Allergy March

The World Allergy Organization estimates that 1.9% to 4.9% of children live with cow's milk allergy (CMA), which positions this disorder among...


20 Apr, 2017, 09:52 ET MGC Diagnostics Announces Clinical Study to Evaluate the Diagnostic Accuracy of the Forced Oscillatory Technique (FOT) to Detect Lung Function Abnormalities

MGC Diagnostics Corporation (NASDAQ: MGCD), a global medical technology company, today announced a new clinical study collaboration with Restech...


20 Apr, 2017, 09:15 ET BioPharmX Completes Last Subject Visit in its Phase 2b Trial of BPX-01, Expects to Report Topline Results First Half of May 2017

BioPharmX Corporation (NYSE MKT: BPMX), a specialty pharmaceutical company developing products for the dermatology market, announced the last...


20 Apr, 2017, 09:10 ET Nektar Therapeutics to Host Analyst & Investor Event at 2017 ASCO Annual Meeting

Nektar Therapeutics (Nasdaq: NKTR) today announced that it will host an analyst and investor event with clinical investigators on Saturday, June 3,...


20 Apr, 2017, 09:00 ET IriSys Contract with NCI for Manufacturing Clinical Trial Materials is Doubled in Value

IriSys, LLC, a San Diego-based provider of contract pharmaceutical product development and manufacturing services, today announced that it was...


20 Apr, 2017, 09:00 ET Gamida Cell Announces Publication of Positive Clinical Outcomes from NiCord-Transplanted Patients in the Journal of Biology of Blood and Marrow Transplantation

Gamida Cell, a leader in cellular and immune therapies for the treatment of cancer and orphan genetic diseases, announced today the publication of...


20 Apr, 2017, 09:00 ET Allergan Partners with TARGET PharmaSolutions to Advance NASH Research

Allergan, a leading global biopharmaceutical company, announced today that it will collaborate with TARGET PharmaSolutions, a clinical data company...


20 Apr, 2017, 08:50 ET Phase 1/2 Clinical Trial of Agenus' anti-PD-1 Antibody Begins

Agenus Inc. (NASDAQ: AGEN), an immuno-oncology (I-O) company with a pipeline of immune checkpoint antibodies and cancer vaccines, today announced...


20 Apr, 2017, 08:45 ET Prominent neurosurgeon and 17-year survivor of brain tumors encourage support for brain tumor research as National Brain Tumor Awareness Month approaches

More than 16,000 U.S. residents die from one of 120 different forms of brain tumors each year. This is a statistic that concerns a highly regarded...


20 Apr, 2017, 08:30 ET New Studies Show Storing Respiratory Devices in Plastic Bags Causes Infections in Hospitals

Infection Prevention Products Inc. has announced today that Hospitals are causing infections by using Plastic Bags to store a patient's reusable...


20 Apr, 2017, 08:00 ET Researchers to Present Updated Clinical Data on Intraoperative Radiation Therapy Using the Xoft System at American Brachytherapy Society (ABS) Annual Meeting

(#T1) -- iCAD, Inc. (Nasdaq: ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early...


20 Apr, 2017, 07:30 ET AbbVie's Investigational, Pan-Genotypic, Ribavirin-free Regimen of Glecaprevir/Pibrentasvir (G/P) Achieved 99 Percent SVR(12) Rate in Chronic Hepatitis C Patients with Compensated Cirrhosis

AbbVie (NYSE: ABBV), a global biopharmaceutical company, today announced that 99 percent (n=145/146) of chronic hepatitis C virus (HCV) infected...


20 Apr, 2017, 03:00 ET Eyevensys Receives Approval From the UK Medicines and Healthcare Products Regulatory Agency to Advance its EyeCET Platform Into Clinical Development

Eyevensys, a private biotechnology company developing its proprietary EyeCET platform, the first non-viral gene expression technology that enables...


20 Apr, 2017, 02:42 ET NeuroVive Presents Preclinical Findings of NV556 in NASH Showing Confirmatory Anti-fibrotic Effects

NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF) ("NeuroVive") today announced positive preclinical results demonstrating...


19 Apr, 2017, 19:51 ET First patients at Vanderbilt University Medical Center implanted in EndoStim's LESS GERD clinical trial for gastroesophageal reflux disease (GERD)

Vanderbilt University Medical Center (VUMC) and EndoStim, Inc., announced that the first patients in Nashville, Tennesse have been implanted with...